Company intelligence / Profile preview

Molecular Radiotherapy and Research Centre

Nashik, Maharashtra, India

Ownership: Private
Development stage: Other

Overview

The Molecular Radiotherapy and Research Centre (MRRC) is a specialized healthcare and research facility focused on the field of theranostics and molecular imaging. Based in India, the center provides advanced diagnostic services using PET-CT and SPECT-CT alongside targeted radionuclide therapies for various malignancies. MRRC integrates clinical care with research initiatives to optimize the use of radiopharmaceuticals like Lu-177 and Ac-225 for treating prostate cancer and neuroendocrine tumors. The center serves as a hub for precision oncology, offering personalized treatment protocols based on molecular targeting.

Therapeutic areas: Oncology
Modalities: RadiopharmaceuticalSmall moleculePeptides
Industry: Academic Hospital/University/Research

Beyond the preview

Go deeper on Molecular Radiotherapy and Research Centre.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Molecular Radiotherapy and Research Centre.

Explore the full profile